Porton Announces Third Quarter 2021 Results
Porton Announces Third Quarter 2021 Results Read More »
Porton Announces Acquisition Of Yuyang Pharmaceutical To Expand Its Manufacturing Capacity
Chongqing, China，August 18, 2021-Porton Pharma Solutions Ltd. (Porton) today announced that it is to acquire 70% of equity of Hubei Yuyang Pharmaceutical Co., Ltd. (Yuyang) with the dealing price of RMB 171.5 million. The acquisition will enhance Porton’s existing capabilities by providing more flexible manufacturing options for the clients. Yuyang’s manufacturing facility is located in
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit (Reproduced)
The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, jointly with our partners XtalPi, BlazeMetrics, and Technobis. The 2-day event includes 4 sessions, with
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit (Reproduced) Read More »
Porton Completes Acquisition of Porton USA
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the previously announced transcation with the shareholders of Porton USA, Inc. (“J-STAR”), a contract chemistry organization
Porton Completes Acquisition of Porton USA Read More »
Porton USA to Acquire Porton USA to Expand Its Research and Development Capabilities
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of Porton USA, Inc. (“J-STAR”), a contract chemistry organization based in South
Porton USA to Acquire Porton USA to Expand Its Research and Development Capabilities Read More »